Medicx Fund Regulatory News (MXF)

For immediate release 15 February 2011

MedicX Fund Limited

("MedicX Fund", "the Fund" or "the Company")

Annual Information Update

MedicX Fund Limited (LSE: MXF), the specialist primary care infrastructure investor in modern purpose-built primary healthcare properties in the United Kingdom, today announces that in accordance with Prospectus Rule 5.2 the following information has been published or made available to the public in compliance with laws and rules dealing with the regulation of securities.

The information referred to in this update was up-to-date at the time of publication but some information may now be out-of-date. The Annual Report and Financial Statements for the year to 30 September 2010 were published on 24 January 2011. The preliminary results announcement was issued on 8 December 2010.

1. Announcements made via RNS, a regulatory information service

Date Brief description of announcement

2 February 2011 Prospectus Published

2 February 2011 Placing / Open Offer / Offer for Subscription

26 January 2011 Interim Management Statement

25 January 2011 Director Declaration

4 January 2011 Allotment of scrip shares to Chairman

4 January 2011 Total Voting Rights

30 December 2010 Additional Listing

8 December 2010 Full Year Results

24 November 2010 Scrip Dividend Scheme

23 November 2010 Circular to Shareholders - Scrip Dividend Scheme

19 November 2010 Acquisition of two new medical centres

18 November 2010 Total Voting Rights

18 November 2010 Issue of new ordinary shares

11 November 2010 Block listing six monthly return

11 November 2010 Quarterly Net Asset Valuation

4 October 2010 Total Voting Rights

4 October 2010 Allotment of scrip shares

29 September 2010 Additional Listing

27 September 2010 Notification of Major Interest in shares

6 September 2010 Notification of Major Interest in shares

3 September 2010 Notification of Major Interest in shares

2 September 2010 Issue of new ordinary shares

2 September 2010 Total Voting Rights

25 August 2010 Scrip Dividend Scheme

23 August 2010 Notification of Major Interest in shares

23 August 2010 Publication of Circular

20 August 2010 Notification of Major Interest in shares

19 August 2010 Notification of Major Interest in shares

12 August 2010 Interim Management Statement

11 August 2010 Notification of Major Interest in shares

10 August 2010 Issue of new ordinary shares

21 July 2010 Acquisition of new primary care medical centre

5 July 2010 Acquisition of new primary care medical centre

5 July 2010 Allotment of scrip shares

5 July 2010 Total Voting Rights

29 June 2010 Additional Listing

4 June 2010 Issue of new ordinary shares

26 May 2010 Results for the six months ended 31 March 2010

21 May 2010 Acquisition

19 May 2010 Scrip Dividend Scheme

17 May 2010 Circular Re Scrip Dividend

11 May 2010 Block listing return

11 May 2010 Acquisition of new primary care medical centre

11 May 2010 Issue date of results

5 May 2010 Notice of dividend and notification of results

6 April 2010 Total Voting Rights

18 March 2010 Notification of Major Interest in shares

17 March 2010 Notification of Major Interest in shares

16 March 2010 Notification of Major Interest in shares

15 March 2010 Notification of Major Interest in shares

11 March 2010 Notification of Major Interest in shares

10 March 2010 Results of Issue

4 March 2010 Notification of Major Interest in shares

4 March 2010 Result of Extraordinary General Meeting

4 March 2010 Placing Announcement

25 February 2010 Acquisition

15 February 2010 Timetable

15 February 2010 Prospectus Published

12 February 2010 Result of AGM

8 February 2010 Interim Management Statement

8 February 2010 Completion of a new medical centre in Abergele

2 February 2010 Annual Information Update

Details of all regulatory announcements can be found in full on the London Stock Exchange's website at www.londonstockexchange.com using the code MXF or on the Company's website at www.medicxfund.com.

2. Company Reports

Copies of all the Company Reports listed below are available from International Administration Guernsey, Regency Court, Glategny Esplanade, St Peter Port, Guernsey.

Date Company Reports

27 January 2011 Annual Report and Financial Statements 2010

7 July 2010 Interim Report 2010

18 January 2010 Annual Report and Financial Statements 2010

3. Documents filed at the Guernsey Company Registry

All of the documents listed below were filed with the Registrar of Companies in Guernsey on or around the dates indicated:

Date Brief description of document Reference

10 March 2010 Resolution - Allotment of Shares 275213

22 February 2010 Resolution - Variation of Class Rights Approval, form 273180

22 February 2010 Resolution - Variation of Class Rights Approval, attachment 273180

22 February 2010 Resolution - Alter Articles, form 273173

22 February 2010 Resolution - Alter Articles, attachment 273173

28 January 2010 Annual Validation 266131

27 January 2010 Change Company Details Form 265872

27 January 2010 Change Company Details Form 265821

Copies of these documents can be obtained on the Guernsey Registry website at www.greg.gg.

4. Documents submitted to the UK Listing Authority and sent to shareholders

All of the documents listed below were submitted to the UK Listing Authority of the Financial Services Authority, at the time, to the Document Viewing Facility situated at:

Financial Services Authority

25 The North Colonnade

Canary Wharf

London E14 5HS

or from 14 May 2010, to the National Storage Mechanism and are available at http://www.hemscott.com/nsm.do

Date Brief description of document

2 February 2011 Prospectus

23 November 2010 Scrip Dividend Circular - December 2010

30 September 2010 Annual Report

14 May 2010 Scrip Dividend Scheme Document

15 February 2010 Prospectus

Copies of the above documents are also available from International Administration Guernsey, Regency Court, Glategny Esplanade, St Peter Port, Guernsey. 

- End -

For further information please contact:

MedicX Group: +44 (0) 1483 869 500

Keith Maddin, Chairman

Mike Adams, Chief Executive Officer

Mark Osmond, Chief Financial Officer

MedicX Fund: +44 (0) 1481 723 450

David Staples, Chairman

Collins Stewart Europe Limited: +44 (0) 20 7523 8000

Andrew Zychowski/Stephen Newby/Helen Goldsmith

Buchanan Communications: +44 (0) 20 7466 5000

Charles Ryland/Suzanne Brocks

Information on MedicX Fund Limited

MedicX Fund Limited ("MXF", the "Fund" or the "Company", or together with its subsidiaries, the "Group") is the specialist primary care infrastructure investor in modern, purpose-built primary healthcare properties in the United Kingdom, listed on the London Stock Exchange, with a portfolio comprising 57 properties.

The Investment Adviser to the Company is MedicX Adviser Ltd, which is authorised and regulated by the Financial Services Authority and is a subsidiary of the MedicX Group. The MedicX Group is a specialist investor, developer and manager of healthcare properties with 30 people operating across the UK.

The Company's website address is www.medicxfund.com. Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website), nor the contents of any website accessible from hyperlinks within this announcement, are incorporated into, or forms part of, this announcement.